Sánchez-Díaz Manuel, López-Delgado David, Montero-Vílchez Trinidad, Salvador-Rodríguez Luis, Molina-Leyva Alejandro, Tercedor-Sánchez Jesús, Arias-Santiago Salvador
Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain.
Paediatric Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain.
J Clin Med. 2021 Sep 20;10(18):4257. doi: 10.3390/jcm10184257.
Oral minoxidil is an approved treatment for high blood pressure which is also used as an off-label drug for alopecia. Knowledge about the effects of systemic minoxidil in the paediatric population is limited. A retrospective case series study of paediatric patients with history of systemic minoxidil intake due to contaminated sets of omeprazole was performed to describe side effects of high dose oral minoxidil intake in children. Twenty patients aged between 2 months and 13 years joined the study. They had received high doses of oral minoxidil (mean dose 0.90 mg/kg/day) during a mean time of 38.3 days. Hypertrichosis appeared in 65%, with a mean latency time of 24.31 days. Treatment time was associated with the appearance of hypertrichosis ( < 0.05). Most common initial zone of hypertrichosis was the face. Systemic effects developed in 15%, with no cases of severe disorders. The present study shows a novel insight into the side effects of high doses of oral minoxidil in children.
口服米诺地尔是一种已获批准的高血压治疗药物,也被用作治疗脱发的非处方药。关于全身性米诺地尔在儿科人群中的作用的知识有限。进行了一项回顾性病例系列研究,研究对象为因受污染的奥美拉唑制剂而有全身性米诺地尔摄入史的儿科患者,以描述儿童高剂量口服米诺地尔摄入的副作用。20名年龄在2个月至13岁之间的患者参与了该研究。他们在平均38.3天的时间内接受了高剂量的口服米诺地尔(平均剂量0.90毫克/千克/天)。65%的患者出现多毛症,平均潜伏期为24.31天。治疗时间与多毛症的出现有关(<0.05)。多毛症最常见的起始部位是面部。15%的患者出现全身效应,无严重疾病病例。本研究为儿童高剂量口服米诺地尔的副作用提供了新的见解。